Categories: News

DAO Labs, Backed by Seasoned Investor Mike Novogratz, to Raise Over $1M Via Reg-CF Offering

Funds will be used to accelerate growth to the company’s DTC and B2B initiatives

MINNEAPOLIS, Aug. 17, 2021 (GLOBE NEWSWIRE) — DAO Labs, a Minneapolis-based health and wellness company that incorporates 2,500-year-old practices of Traditional Chinese Medicine into modern formats allowing customers to live more active, fuller lives, has recently unveiled plans to raise $1.07 million in a strategic effort to accelerate growth during an era where widespread physical and mental health is crucial. The fundraising campaign not only serves as an investment in an exponential growth category but also a long-term investment in a personal health and wellness journey. Billionaire investor and Galaxy Digital CEO, Mike Novogratz is an early investor in the company.

Dr. Eric Karchmer, Co-founder and Chief Doctor at DAO Labs, is a current recipient of a Fulbright Scholarship to research Traditional Chinese Medicine in Asia. “I’ve been practicing Traditional Chinese Medicine for nearly 30 years. The most thrilling aspect of DAO Labs for me is that in a very short time I have helped more people with Chinese medicine than in decades of clinical practice,” said Dr. Karchmer. “It’s an honor to now be learning from the best of Taiwan’s Chinese medicine community in order to further expand the offerings from DAO Labs.”

Studies show that due to the global pandemic, interest in alternative healthcare has skyrocketed and the global market for botanicals and acupuncture reveals a CAGR of 19.8% to $165 billion by the year 2027. DAO Labs’ fundraising efforts will provide great growth opportunities to help meet this demand, including advancements in tele-health through the company’s virtual consultations initiative, accelerated growth to DTC and B2B initiatives, and additional health and wellness approaches for alternative healthcare. “With interest in Traditional Chinese Medicine at a record high, we’re excited to be in such a compelling position to respond to this demand,” said John G. McGarvey, Co-founder of DAO Labs. “From our sleep formulas to our brand new and very timely cold season solutions, we’re helping more people achieve their health goals in authentic, time-tested, natural ways.”

In addition to an impressive portfolio of dietary supplement categories that are quickly expanding, DAO Labs boasts a dedicated global network of alternative healthcare providers with tremendous room to scale. Most recently, in response to the global healthcare crisis, the company launched two herbal tablets that provide natural strength and support to symptoms such as fevers, aches and coughs. These new formulas are expected to be top sellers as we approach another cold season.

To learn more about DAO Labs and products, please visit: https://mydaolabs.com
To become a DAO Labs investor, please visit: https://www.startengine.com/dao-labs

CONTACT: Evan Sneider
Red Rooster PR
esneider@redroosterpr.com
954-673-6835

Staff

Recent Posts

Bemax Announces Financial Results for Fiscal Fourth Quarter Ended May 31, 2024

- Revenue increase of over 600%Dallas, Georgia--(Newsfile Corp. - July 2, 2024) - Bemax Inc.…

1 hour ago

1933 Industries Reports Profit in Q3 2024 Financials

VANCOUVER, BC / ACCESSWIRE / July 2, 2024 / 1933 Industries Inc. (the "Company" or…

1 hour ago

Myriad Genetics Earns 2024 Great Place To Work® Certification™

SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a…

1 hour ago

Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York

The ceremony will be held in celebration of Scilex’s launch of GLOPERBA®, an innovative non-opioid…

1 hour ago

Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024

July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG…

1 hour ago